Page last updated: 2024-08-22

sizofiran and Peritoneal Carcinomatosis

sizofiran has been researched along with Peritoneal Carcinomatosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ohara, N; Teramoto, K	1
Chen, JT; Hasumi, K; Masubuchi, K; Shimizu, Y; Teshima, H	1

Other Studies

2 other study(ies) available for sizofiran and Peritoneal Carcinomatosis

Article	Year
Successful treatment of pseudomyxoma peritonei with intraperitoneal 10 per cent dextrose, sizofiran and cisplatin. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2002, Volume: 22, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Doxorubicin; Female; Glucose Solution, Hypertonic; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Sizofiran; Treatment Outcome	2002
[Effect of sizofiran or recombinant interferon gamma on the activation of human peritoneal macrophage function; an approach for the prophylaxis of intraperitoneal recurrence of ovarian cancer]. Nihon Sanka Fujinka Gakkai zasshi, 1990, Volume: 42, Issue:2 Topics: Adult; Drug Therapy, Combination; Female; Glycosaminoglycans; Humans; Interferon-gamma; Interleukin-1; Macrophage Activation; Macrophages; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Peritoneal Neoplasms; Recombinant Proteins; Recurrence; Sizofiran	1990

Article

Year

Successful treatment of pseudomyxoma peritonei with intraperitoneal 10 per cent dextrose, sizofiran and cisplatin.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2002, Volume: 22, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Doxorubicin; Female; Glucose Solution, Hypertonic; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Sizofiran; Treatment Outcome

2002

[Effect of sizofiran or recombinant interferon gamma on the activation of human peritoneal macrophage function; an approach for the prophylaxis of intraperitoneal recurrence of ovarian cancer].

Nihon Sanka Fujinka Gakkai zasshi, 1990, Volume: 42, Issue:2

Topics: Adult; Drug Therapy, Combination; Female; Glycosaminoglycans; Humans; Interferon-gamma; Interleukin-1; Macrophage Activation; Macrophages; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Peritoneal Neoplasms; Recombinant Proteins; Recurrence; Sizofiran

1990